Literature DB >> 15474336

Breast cancer: the role of angiogenesis and antiangiogenic therapy.

Kathy D Miller1, Carrie L Dul.   

Abstract

Angiogenesis plays a role in breast cancer development. Preclinical and clinical evidence is reviewed. Development of targeted antiangiogenic agents provides new challenges to clinical trial design. Current antiangiogenic therapy with traditional agents and novel agents are classified and reviewed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15474336     DOI： 10.1016/j.hoc.2004.06.010

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  5 in total

1.  No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.

Authors:  Tsogzolmaa Dorjgochoo; Ying Zheng; Yu-Tang Gao; Xiangyu Ma; Jirong Long; Pingping Bao; Ben Zhang; Wanqing Wen; Wei Lu; Wei Zheng; Xiao Ou Shu; Alicia Beeghly-Fadiel
Journal:  Cancer Epidemiol       Date:  2013-07-11       Impact factor: 2.984

Review 2.  Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland.

Authors:  Carmen Clapp; Stéphanie Thebault; Gonzalo Martínez de la Escalera
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

3.  High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.

Authors:  Sriparna Ghosh; Catherine A W Sullivan; Maciej P Zerkowski; Annette M Molinaro; David L Rimm; Robert L Camp; Gina G Chung
Journal:  Hum Pathol       Date:  2008-08-20       Impact factor: 3.466

4.  Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.

Authors:  Guobing Li; Changyu Shan; Lei Liu; Ting Zhou; Jing Zhou; Xiaoye Hu; Yibiao Chen; Hongjuan Cui; Ning Gao
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

5.  Dietary protein sources and tumoral overexpression of RhoA, VEGF-A and VEGFR2 genes among breast cancer patients.

Authors:  Ali Shokri; Saeed Pirouzpanah; Mitra Foroutan-Ghaznavi; Vahid Montazeri; Ashraf Fakhrjou; Hojjatollah Nozad-Charoudeh; Gholamreza Tavoosidana
Journal:  Genes Nutr       Date:  2019-07-09       Impact factor: 5.523
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.